(Q45066824)

English

GLP-1 and peptide YY secretory response after fat load is impaired by insulin resistance, impaired fasting glucose and type 2 diabetes in morbidly obese subjects.

scientific article published on 6 May 2013

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23573808%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

GLP-1 and peptide YY secretory response after fat load is impaired by insulin resistance, impaired fasting glucose and type 2 diabetes in morbidly obese subjects (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23573808%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

0 references

type 2 diabetes

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

José Carlos Fernández-García

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23573808%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Mora Murri

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23573808%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Leticia Coin-Aragüez

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23573808%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Juan Alcaide

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23573808%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Rajaa El Bekay

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23573808%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Francisco J Tinahones

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23573808%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

6 May 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23573808%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Clinical Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23573808%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

80

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23573808%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23573808%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

671-676

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23573808%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

The gut hormones in appetite regulation

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Gut hormones and appetite control

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Peptide YY is secreted after oral glucose administration in a gender-specific manner

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

GLP-1 and extra-islet effects

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Glucagon-like peptide-1: a potent regulator of food intake in humans

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Inhibition of food intake in obese subjects by peptide YY3-36

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Nutritional regulation of glucagon-like peptide-1 secretion

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Peptide YY(1-36) and peptide YY(3-36): Part I. Distribution, release and actions

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Fasting plasma peptide-YY concentrations are elevated but do not rise postprandially in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Attenuated GLP-1 secretion in obesity: cause or consequence?

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Growth hormone, ghrelin and peptide YY secretion after oral glucose administration in healthy and obese women.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Plasma glucagon-like peptide-1 (GLP-1) responses to duodenal fat and glucose infusions in lean and obese men.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Hyperglycemia acutely lowers the postprandial excursions of glucagon-like Peptide-1 and gastric inhibitory polypeptide in humans

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Standards of medical care in diabetes--2011.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Prediction of glucose and insulin resistance disorders by using anthropometric parameters of central adiposity: PRED-IR study

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Insulin resistance quantification by fasting insulin plasma values and HOMA index in a non-diabetic population

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Effect of macronutrient composition on postprandial peptide YY levels

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Variation of postprandial PYY 3-36 response following ingestion of differing macronutrient meals in obese females

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Interaction between specific fatty acids, GLP-1 and insulin secretion in humans

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Effect of human body weight changes on circulating levels of peptide YY and peptide YY3-36.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Decreased glucagon-like peptide 1 fasting levels in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Effect of nutrient ingestion on glucagon-like peptide 1 (7-36 amide) secretion in human type 1 and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Glucagon-like peptide-1 release and satiety after a nutrient challenge in normal-weight and obese subjects

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Attenuated peptide YY release in obese subjects is associated with reduced satiety.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

The distinction of metabolically 'healthy' from 'unhealthy' obese individuals

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Obesity-associated insulin resistance is correlated to adipose tissue vascular endothelial growth factors and metalloproteinase levels

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Study of the potential association of adipose tissue GLP-1 receptor with obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12221

21 January 2018

Identifiers

10.1111/CEN.12221

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23573808%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23573808%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45066824&oldid=1538991774"